Plant-Based Online Weight Loss Through Education and Resources Program and Study
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Physicians Committee for Responsible Medicine
- Study ID
- NCT07095543
- Status
- Recruiting
Conditions
- Overweight and Obese Adults
- Type 2 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Low-fat, vegan diet — BEHAVIORALAll participants will be asked to follow a low-fat vegan diet for the duration of the study. Participants will attend weekly classes where they we receive education and support.
Study Details
This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Participants will meet with a physician and a registered dietitian once a week to learn about a plant-based diet and receive support and practical help in making the dietary changes. Body composition, blood sugar control, cholesterol levels, and food costs will be measured at the start and end of the study.
Key Dates
- First listed
- Jul 31, 2025
- Start date
- Jan 2, 2026
- Status verified
- Sep 2026
- Primary completion
- Oct 1, 2028
- Completion
- Oct 30, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Low-fat, vegan dietAll participants will be asked to follow a low-fat vegan diet. There are no other study arms or control group.
Primary Outcome Measure
The feasibility of an online plant-based weight loss program in the community setting. [ Time Frame: From baseline to the end of the intervention at 12 weeks. ]
Central Contacts
- Vanita Rahman, MD, DipACLM202-527-7500
- Shannon Menhardt, MS, RD202-527-7500
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Physicians Committee for Responsible Medicine | Washington D.C. | District of Columbia | 20016 |
Find similar trials in Washington D.C., DC
By condition
By specialty
Related Studies
- Diabetes Reversal Online Program and Study (DROP Study)Recruiting · Physicians Committee for Responsible Medicine · Washington D.C., District of Columbia
- Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort StudyRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Washington D.C., District of Columbia
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)PHASE3 · Recruiting · Eli Lilly and Company · Tucson, Arizona
- The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older AdultsRecruiting · AdventHealth Translational Research Institute · Orlando, Florida